Shoji Sunao, Usui Yukio, Nakano Mayura, Hanai Kazuya, Sato Haruhiro, Uchida Toyoaki, Terachi Toshiro
Department of Urology, Tokai University School of Medicine, Tokyo 192-0032, Japan.
Oncol Lett. 2010 Nov;1(6):967-971. doi: 10.3892/ol.2010.183. Epub 2010 Sep 23.
The present study aimed to clarify decision-making factors based on imaging for laparoscopic adrenalectomy (LA) or open adrenalectomy (OA) for adrenal metastasis (AM) based on our previous experience. From November 2003 to November 2006, 11 adrenalectomies were performed for AM for malignancies such as lung cancer, renal cell carcinoma (RCC) and breast cancer at Tokai University Hospital. A diagnosis of AM for these malignancies was suspected whenever a newly diagnosed adrenal mass was located, characterized by a basal computed tomography (CT) density superior to 10 Hounsfield units, strong or heterogeneous vascular enhancement following contrast injection and/or increasing size in sequential imaging studies. There was no evidence of extra-AM. The approach to surgical management using LA or OA was determined on the basis of CT and/or magnetic resonance imaging. The patients were reviewed every 2 or 3 months by physical examination and systemic CT. We analyzed the decision-making factors based on imaging for surgical management with LA or OA from the results of oncological outcome, imaging, intraoperative and pathohistological findings. In this study, 9 patients underwent 11 adrenalectomies (9 laparoscopic and 2 open procedures). Non-small cell lung cancer was the most common primary malignancy (5 adrenalectomies of 4 patients), followed by RCC (4 adrenalectomies of 4 patients) and breast cancer (2 adrenalectomies of 1 patient). The median tumor size for the LA group was 3.1±0.7 cm (range 2.1-4.3) and for the OA group, 6.1±0.8 cm (5.5 and 6.7 cm) (p=0.001). The operative time for the LA group was 127±42 min (range 90-215) and for the OA group, 224±47 min (190 and 257 min) (p=0.018). Blood loss for the LA group was 49±63 g (range 3-207) and for the OA group, 340±10 g (333 and 347 g) (p<0.001). No complications were noted and no conversion of LA to OA occurred. All 9 adrenal tumors selected for LA were removed safely without strong adhesion to the surrounding tissue. Two adrenal tumors removed by OA had a strong adhesion to the surrounding tissue. All 9 patients had complete resection, without capsular disruption and a negative margin in the pathological findings. No port-site and local recurrences occurred. No patients presented with local relapse or port-site metastasis. Disease-free survival rate for the LA group was 57% and for the OA group, 50% (p=0.661). LA is a less invasive treatment than OA for AM. However, for complete resection, OA should be selected for cases where resection by LA is difficult. Therefore, in the decision making towards the appropriate surgical management with LA or OA, it is important to closely assess pre-operative imaging. Imaging features supporting OA include no detection of fatty tissue between the tumor and proximal organs, tumors with an irregular contour, large tumors and tumors with a cystic component.
基于我们之前的经验,本研究旨在阐明针对肾上腺转移瘤(AM)行腹腔镜肾上腺切除术(LA)或开放性肾上腺切除术(OA)时基于影像学的决策因素。2003年11月至2006年11月,东海大学医院对肺癌、肾细胞癌(RCC)和乳腺癌等恶性肿瘤的AM患者进行了11例肾上腺切除术。只要新诊断出的肾上腺肿块具有以下特征,即怀疑为这些恶性肿瘤的AM:基础计算机断层扫描(CT)密度高于10亨氏单位、注射造影剂后有强烈或不均匀的血管强化和/或在连续影像学检查中体积增大。无肾上腺外转移的证据。根据CT和/或磁共振成像确定采用LA或OA的手术治疗方法。通过体格检查和全身CT每2或3个月对患者进行复查。我们根据肿瘤学结局、影像学、术中及病理组织学结果分析了基于影像学对LA或OA手术治疗的决策因素。本研究中,9例患者接受了11次肾上腺切除术(9例腹腔镜手术和2例开放手术)。非小细胞肺癌是最常见的原发恶性肿瘤(4例患者行5次肾上腺切除术),其次是RCC(4例患者行4次肾上腺切除术)和乳腺癌(1例患者行2次肾上腺切除术)。LA组肿瘤的中位大小为3.1±0.7 cm(范围2.1 - 4.3 cm),OA组为6.1±0.8 cm(5.5和6.7 cm)(p = 0.001)。LA组的手术时间为127±42分钟(范围90 - 215分钟),OA组为224±47分钟(190和257分钟)(p = 0.018)。LA组的失血量为49±63克(范围3 - 207克),OA组为340±10克(333和347克)(p < 0.001)。未观察到并发症,也未发生LA转为OA的情况。所有选择LA的9个肾上腺肿瘤均安全切除,与周围组织无紧密粘连。通过OA切除的2个肾上腺肿瘤与周围组织有紧密粘连。所有9例患者均实现了完整切除,病理结果显示无包膜破裂且切缘阴性。未发生切口部位和局部复发。无患者出现局部复发或切口部位转移。LA组的无病生存率为57%,OA组为50%(p = 0.661)。对于AM,LA是一种比OA侵入性更小的治疗方法。然而,为了完整切除,对于LA难以切除的病例应选择OA。因此,在决定采用LA或OA进行合适的手术治疗时,密切评估术前影像学很重要。支持OA的影像学特征包括肿瘤与近端器官之间未检测到脂肪组织、轮廓不规则的肿瘤、大肿瘤以及有囊性成分的肿瘤。